Effect of tea flavonoid supplementation on the susceptibility of low- density lipoprotein to oxidative modification

American Journal of Clinical Nutrition

Volumn 66, Issue 2, 1997, Pages 261-266

  Ishikawa, Toshitsugu ^a   Suzukawa, Michio ^b   Ito, Toshimitsu ^b   Yoshida, Hiroshi ^b   Ayaori, Makoto ^b   Nishiwaki, Masato ^b   Yonemura, Atsushi ^b   Hara, Yukihiko ^b   Nakamura, Haruo ^b  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b NONE

Author keywords

Atherosclerosis; Catechin; Epicatechin; Epicatechin gallate; Epigallocate chin; Epigallocatechin gallate; Humans; LDL; Low density lipoprotein; Macrophage; Oxidation; Tea flavonoids; Theaflavin digallate; Theaflavin monogallate; Theaflavins

Indexed keywords

ALKADIENE; ALPHA TOCOPHEROL; APOLIPOPROTEIN B; CATECHIN; CHOLESTEROL; COPPER SULFATE; EPICATECHIN; EPICATECHIN GALLATE; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; FLAVONOID; LIPID PEROXIDE; LOW DENSITY LIPOPROTEIN; POLYPHENONE E; THEAFLAVIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; HUMAN; HUMAN EXPERIMENT; LIPID OXIDATION; MACROPHAGE; MALE; NORMAL HUMAN; PLASMA; TEA; TRIACYLGLYCEROL BLOOD LEVEL; ULTRACENTRIFUGATION;

CAMELLIA SINENSIS;

EID: 0030739655     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/66.2.261     Document Type: Article

References (31)

1. Witztum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 1991;88:1785-92.
2. Parthasarathy S, Young SG, Witztum JL, Pittman RC, Steinberg D. Probucol inhibits oxidative modification of low density lipoprotein. J Clin Invest 1986;77:641-4.
3. Abbey M, Nestel PL, Baghurst PA. Antioxidant vitamin and low-density-lipoprotein oxidation. Am J Clin Nutr 1993;58:525-32.
4. Suzukawa M, Ishikawa T, Yoshida H, Nakamura H. Effect of in vivo supplementation with low-dose vitamin E on susceptibility of low-density lipoprotein and high-density lipoprotein to oxidative modification. J Am Coll Nutr 1995;14:46-52.
5. Gey KF, Puska P, Jordan P, Moser UK. Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. Am J Clin Nutr 1991;53:326S-34S.
6. Rimm EB, Stampfer MJ, Ascherio A, Givannucci E, Golditz GA, Willett W. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993;328:1450-6.
7. Todd J, Anderson L, Meredith I, et al. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med 1995;332:4S88-93.
8. Regnström J, Nilsson J, Tornvall P, Landou C, Hamsten A. Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man. Lancet 1992;339:1183-186.
9. Hertog MGL, Feskns EJM, Hollman PCH, Katan MB, Komhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 1993;342:1007-11.
10. Hertog MGL, Kromhout D, Aravanis C, et al. Flavonoid intake and long-term risk of coronary heart disease and cancer in the Seven Countries Study. Arch Intern Med 1995;155:381-6.
11. Renaud S, de Lorgeril M. Wine, alcohol, platelets and the French paradox for coronary heart disease. Lancet 1992;339:1523-6.
12. Frankel EN, Kanner J, German JB, Parks E, Kinsella JE. Inhibition of oration of human low-density lipoprotein by phenolic substances in red wine. Lancet 1993;341:454-7.
13. de Rijke YB, Demacker PNM, Assen NA, Sloots LM, Katan MB, Stalenhoef AFH. Red wine consumption does not affect oxidizability of low-density lipoproteins in volunteers. Am J Clin Nutr 1996;63:329-34.
14. Haratz D, Ben-Naim M, Dabach Y, Hollander G, Stein O, Stein Y. Cigarette smoking renders LDL susceptible to peroxidative modification and enhanced metabolism by macrophages. Atherosclerosis 1989;79:245-52.
15. Stehle G, Hinohara S, Gross K, et al. Influence of alcohol consumption, smoking, and exercise habits on blood lipoprotein concentrations in 9256 healthy Japanese adults. In: Schettler G, ed. Endemic diseases and risk factors for atherosclerosis in the Far East.. Berlin: Springer Verlag, 1988:13-25.
16. Graham HN. Green tea composition, consumption, and polyphenol chemistry. Prev Med 1992;21:334-50.
17. 2+-mediated oxidative modification of low density lipoprotein. Biol Pharm Bull 1995;18:1-4.
18. Mangiapane H, Thomson J, Salter A, Brown S, Bell GD, White DA. The inhibition of the oxidation of low density lipoprotein by (+)-catechin, a naturally occurring flavonoid. Biochem Pharmacol 1992;43:445-50.
19. Hara Y. Prophylactic functions of tea polyphenols. In: Ho CT, Osawa T, Huang MT, Rosen RT, eds. Food phytochemicals for cancer prevention II. Washington, DC: American Chemical Society 1994:34-50.
20. Chung BH, Segrest JP, Ray MJ, et al. Single vertical spin gradient ultracentrifugation. Methods Enzymol 1986;128:181-209.
21. Esterbauer H, Striegl H, Puhl H, Rotheneder M. Continuous monotoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun 1989;6:67-75.
22. Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol 1978;52:302-10.
23. Maciejiko JJ, Levinson SS, Markyvech L, Smith MP, Blevins RD. New assay of apolipoprotein A-1 and B by rate nephelometry evaluation. Clin Chem 1987;33:2065-9.
24. Van Vliet T, Van Schaik F, Van Schoonhoven J, Schrijiver J. Determination of several retinoids, carotenoids, and E vitamins by HPLC: application to plasma and tissues of rats fed a diet rich in either beta-carotene or canthaxanthin. J Chromatogr 1984;305:53-60.
25. De Whalley CV, Rankin SM, Hoult JRS, Jessup W. Flavonoids inhibit the oxidative modification of low density lipoproteins by macrophages. Biochem Pharmacol 1990;39:1743-50.
26. Wu T-W, Fung K-P, Yang C-C, Weisel RD. Antioxidation of human low density lipoprotein by morin hydrate. Life Sci 1995;57:PL51-6.
27. Afanas'ev IB, Dorozhko AI, Brodoskii AV, Kostyuk VA, Potapovitch AI. Chelating and free radical scavenging mechanisms of inhibitory action of rutin and quercetin in lipid peroxidation. Biochem Pharmacol 1989;38:1763-9.
28. Husain SR, Cillard J, Cillard P. Hydroxyl radical scavenging activity of flavonoids. Phytochemistry 1987;26:2489-91.
29. Thompson M, Williams CR, Elliot GEP. Stability of flavonoid complexes of copper (II) and flavonoid antioxidant activity. Anal Chim Acta 1976;85:375-81.
30. Unno T, Takeo T. Absorption of (-)-epigallocatechin gallate into the circulation system of rats. Biosci Biotech Biochem 1995; 59:1558-9.
31. Lee M-J, Wang Z-Y, Li H, et al. Analysis of plasma and urinary tea polyphenols in human subjects. Cancer Epidemiol Biomarkers Prev 1995;4:393-9.